Moffitt Cancer Center study shows promising clinical activity

(H. Lee Moffitt Cancer Center & Research Institute) Immune cellular therapy is a promising new area of cancer treatment. Anti-cancer therapeutics, such as chimeric antigen receptor modified T cells, can be engineered to target tumor-associated antigens to attack and kill cancer cells. This allows for an improved precision medicine approach to treating cancer.